Research programme: pain therapy - NobexAlternative Names: pain therapy research programme - Nobex
Latest Information Update: 31 Mar 2004
At a glance
- Originator Nobex Corporation
- Mechanism of Action Opioid receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 31 Mar 2004 Discontinued - Preclinical for Pain in USA (unspecified route)
- 19 Mar 2002 Preclinical trials in Pain in USA (unspecified route)